Search results
Results From The WOW.Com Content Network
COVID-19. Pfizer. 3C-like protease inhibitor (Nirmatrelvir) / inhibition of metabolism of nirmatrelvir (ritonavir) Nevirapine. HIV. non- nucleoside reverse transcriptase inhibitor. Nitazoxanide. Broad-spectrum antiviral.
Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. [ 5 ] Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. [ 6 ]
Antiretroviral drugs for HIV. Antiviral drugs are a class of medication used for treating viral infections. [1] Most antivirals target specific viruses, while a broad-spectrum antiviral is effective against a wide range of viruses. [2] Antiviral drugs are a class of antimicrobials, a larger group which also includes antibiotic (also termed ...
Strep throat, a bacterial infection, is the cause in about 25% of children and 10% of adults. [2] Uncommon causes include other bacteria such as gonococcus, fungi, irritants such as smoke, allergies, and gastroesophageal reflux disease. [2] [4] Specific testing is not recommended in people who have clear symptoms of a viral infection, such as a ...
Here’s what to know. Hanh Truong. If you recently tested positive for COVID-19, you may be eligible for antiviral treatments to help reduce your infection. Earlier this year, when the omicron ...
Influenza, commonly known as " the flu " or just " flu ", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin one to four (typically two) days after exposure to the virus and last for about ...
Antiviral drugs directly target the viruses responsible for influenza infections. Generally, anti-viral drugs work optimally when taken within a few days of the onset of symptoms. [3] Certain drugs are used prophylactically, that is they are used in uninfected individuals to guard against infection. [medical citation needed]
In May 2022, Pfizer suggested repeating the treatment, but the FDA said there was no evidence of benefit. [38] [39] In June 2022, a US case report of ten people with rebound COVID‑19 had found viral load during relapse was comparable to levels during an initial infection, and high enough to cause secondary transmission. [40]